Literature DB >> 30361804

Replication study of GWAS risk loci in Greek multiple sclerosis patients.

Georgios M Hadjigeorgiou1, Persia-Maria Kountra2, Georgios Koutsis3, Vana Tsimourtou2, Vasileios Siokas2, Maria Dardioti2, Dimitrios Rikos2, Chrysoula Marogianni2, Athina-Maria Aloizou2, Georgia Karadima3, Styliani Ralli2, Nikolaos Grigoriadis4, Dimitrios Bogdanos5, Marios Panas3, Efthimios Dardiotis2.   

Abstract

OBJECTIVES: To validate in an ethnically homogeneous Greek multiple sclerosis (MS) cohort, genetic risk factors for the disease, identified through a number of previous multi-ethnic genome-wide association studies (GWAS).
METHODS: A total of 1228 MS cases and 1014 controls were recruited in the study, from 3 MS centers in Greece. We genotyped 35 susceptibility SNPs that emerged from previous GWAS or meta-analyses of GWAS. Allele and genotype single locus regression analysis, adjusted for gender and site, was performed. Permutation testing was applied to all analyses.
RESULTS: Six polymorphisms reached statistical significance (permutation p value < 0.05). In particular, rs2760524 of LOC105371664, near RGS1 (permutation p value 0.001), rs3129889 of HLA-DRA, near HLA-DRB1 (permutation p value < 1.00e-04), rs1738074 of TAGAP (permutation p value 0.007), rs703842 of METTL1/CYP27B1 (permutation p value 0.008), rs9596270 of DLEU1 (permutation p value < 1.00e-04), and rs17445836 of LincRNA, near IRF8 (permutation p value 0.001) were identified as susceptibility risk factors in our group.
CONCLUSION: The current study replicated a number of GWAS susceptibility SNPs, which implies that some similarities between the examined Greek population and the MS genetic architecture of the GWAS populations do exist.

Entities:  

Keywords:  Genetic architecture; Genetic variants; Multiple sclerosis; Risk factors; SNPs; Susceptibility

Mesh:

Year:  2018        PMID: 30361804     DOI: 10.1007/s10072-018-3617-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  40 in total

Review 1.  New approaches to investigating heterogeneity in complex traits.

Authors:  R Bomprezzi; P E Kovanen; R Martin
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

2.  SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci.

Authors:  Yong Yong Shi; Lin He
Journal:  Cell Res       Date:  2005-02       Impact factor: 25.617

Review 3.  Epidemiology and genetics of multiple sclerosis.

Authors:  A Compston; A D Sadovnick
Journal:  Curr Opin Neurol Neurosurg       Date:  1992-04

4.  Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.

Authors:  David A Dyment; Blanca M Herrera; M Zameel Cader; Cristen J Willer; Matthew R Lincoln; A Dessa Sadovnick; Neil Risch; George C Ebers
Journal:  Hum Mol Genet       Date:  2005-06-01       Impact factor: 6.150

5.  Measuring European population stratification with microarray genotype data.

Authors:  Marc Bauchet; Brian McEvoy; Laurel N Pearson; Ellen E Quillen; Tamara Sarkisian; Kristine Hovhannesyan; Ranjan Deka; Daniel G Bradley; Mark D Shriver
Journal:  Am J Hum Genet       Date:  2007-03-22       Impact factor: 11.025

6.  Structural diversity in the RGS domain and its interaction with heterotrimeric G protein alpha-subunits.

Authors:  Meera Soundararajan; Francis S Willard; Adam J Kimple; Andrew P Turnbull; Linda J Ball; Guillaume A Schoch; Carina Gileadi; Oleg Y Fedorov; Elizabeth F Dowler; Victoria A Higman; Stephanie Q Hutsell; Michael Sundström; Declan A Doyle; David P Siderovski
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

7.  Cognitive presentation of multiple sclerosis: evidence for a cortical variant.

Authors:  M Zarei; S Chandran; A Compston; J Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

8.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

9.  Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.

Authors:  Philip L De Jager; Xiaoming Jia; Joanne Wang; Paul I W de Bakker; Linda Ottoboni; Neelum T Aggarwal; Laura Piccio; Soumya Raychaudhuri; Dong Tran; Cristin Aubin; Rebeccah Briskin; Susan Romano; Sergio E Baranzini; Jacob L McCauley; Margaret A Pericak-Vance; Jonathan L Haines; Rachel A Gibson; Yvonne Naeglin; Bernard Uitdehaag; Paul M Matthews; Ludwig Kappos; Chris Polman; Wendy L McArdle; David P Strachan; Denis Evans; Anne H Cross; Mark J Daly; Alastair Compston; Stephen J Sawcer; Howard L Weiner; Stephen L Hauser; David A Hafler; Jorge R Oksenberg
Journal:  Nat Genet       Date:  2009-06-14       Impact factor: 38.330

10.  Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip.

Authors:  Chris C A Spencer; Zhan Su; Peter Donnelly; Jonathan Marchini
Journal:  PLoS Genet       Date:  2009-05-15       Impact factor: 5.917

View more
  9 in total

Review 1.  Towards a global view of multiple sclerosis genetics.

Authors:  Huw R Morris; Ruth Dobson; Benjamin Meir Jacobs; Michelle Peter; Gavin Giovannoni; Alastair J Noyce
Journal:  Nat Rev Neurol       Date:  2022-09-08       Impact factor: 44.711

2.  Matching tRNA modifications in humans to their known and predicted enzymes.

Authors:  Valérie de Crécy-Lagard; Pietro Boccaletto; Carl G Mangleburg; Puneet Sharma; Todd M Lowe; Sebastian A Leidel; Janusz M Bujnicki
Journal:  Nucleic Acids Res       Date:  2019-03-18       Impact factor: 16.971

3.  Downregulation of long noncoding RNA DLEU1 attenuates hypersensitivity in chronic constriction injury-induced neuropathic pain in rats by targeting miR-133a-3p/SRPK1 axis.

Authors:  Zhen Li; Aiyuan Li; Liping Yan; Tian Yang; Wei Xu; Pengju Fan
Journal:  Mol Med       Date:  2020-11-10       Impact factor: 6.354

4.  Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews.

Authors:  Alexios-Fotios A Mentis; Efthimios Dardiotis; Vasiliki Efthymiou; George P Chrousos
Journal:  BMC Med       Date:  2021-01-13       Impact factor: 8.775

Review 5.  Thinking outside the Ischemia Box: Advancements in the Use of Multiple Sclerosis Drugs in Ischemic Stroke.

Authors:  Athina-Maria Aloizou; Vasileios Siokas; Georgia Pateraki; Ioannis Liampas; Christos Bakirtzis; Zisis Tsouris; George Lazopoulos; Daniela Calina; Anca Oana Docea; Aristidis Tsatsakis; Dimitrios P Bogdanos; Efthimios Dardiotis
Journal:  J Clin Med       Date:  2021-02-07       Impact factor: 4.241

6.  Brain Awareness Week, CoVID-19 infection and Neurological Sciences.

Authors:  Antonio Federico
Journal:  Neurol Sci       Date:  2020-04       Impact factor: 3.307

7.  Multiple Sclerosis: Shall We Target CD33?

Authors:  Vasileios Siokas; Zisis Tsouris; Athina-Maria Aloizou; Christos Bakirtzis; Ioannis Liampas; Georgios Koutsis; Maria Anagnostouli; Dimitrios P Bogdanos; Nikolaos Grigoriadis; Georgios M Hadjigeorgiou; Efthimios Dardiotis
Journal:  Genes (Basel)       Date:  2020-11-12       Impact factor: 4.096

8.  Association of multiple sclerosis with vitiligo: a systematic review and meta-analysis.

Authors:  Meng-Han Shen; Chau Yee Ng; Kuo-Hsuan Chang; Ching-Chi Chi
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

Review 9.  Human transfer RNA modopathies: diseases caused by aberrations in transfer RNA modifications.

Authors:  Takeshi Chujo; Kazuhito Tomizawa
Journal:  FEBS J       Date:  2021-02-16       Impact factor: 5.622

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.